Navigation Links
China Nepstar Chain Drugstore (NPD) Begins Trading on NYSE
Date:11/9/2007

SHENZHEN, China and NEW YORK, Nov. 9 /PRNewswire-FirstCall/ -- China's largest drugstore chain based on the number of directly operated stores, China Nepstar Chain Drugstore Ltd (NYSE: NPD) ("Nepstar" or "the Company"), was listed today on the New York Stock Exchange.

Nepstar offered 20,625,000 American depositary shares (ADSs) during its initial public offering at US$16.20 each. Gross proceeds from the offering, not including the potential exercise of the greenshoe, amounted to approximately US$334 million.

Nepstar is the largest drugstore chain in mainland China, with 1,791 directly operated stores as of September 30, 2007.

Proceeds from the offering will be used to open new stores, to upgrade information management and inventory control systems and to set up two new distribution centers. The proceeds may also be used for other general corporate purposes and for potential acquisitions.

Goldman Sachs (Asia) L.L.C. was the sole global coordinator of the offering. Goldman Sachs (Asia) L.L.C. and Merrill Lynch, Pierce, Fenner & Smith Incorporated were the joint bookrunners. CLSA Limited was also an underwriter of the offering.

Nepstar's registration statement relating to these securities has been declared effective by the United States Securities and Exchange Commission. This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of the securities is made only by means of a
'/>"/>

SOURCE China Nepstar Chain Drugstore Ltd
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... require that certain businesses with large areas where people gather, ... available. Fire and rescue personnel agree that for any size ... , ... Issaquah, WA (PRWEB) December ... that certain businesses with large areas where people gather, need ...
(Date:12/15/2009)... SAN DIEGO, Dec. 15 "The entire San ... mourns the passing of Sol Price on December 14, ... standards of integrity, loyalty and ethics in his business, ... and thoughtful humanitarian who truly understood the responsibility of ... and his legacy will live on through his countless ...
(Date:12/15/2009)... UT Southwestern Medical Center researchers have provided ... unique observable characteristics seen in patients with an ... reported online and in the December issue of ... suggest that patients with atypical progeroid syndrome ... diagnosed with two similar but more well-defined accelerated ...
(Date:12/14/2009)... and synthetic red-blood-cell-like particles carry oxygen, drugs, and more… ... ... Scientists at UC Santa Barbara, in collaboration with scientists at ... the characteristics and key functions of natural red blood cells, ... , , , , ,The primary function of natural red ...
(Date:12/14/2009)... Fla., Dec. 14 Abbott (NYSE: ... definitive agreement to acquire STARLIMS Technologies Ltd. ... of laboratory information management systems, for approximately ... acquisition strengthens Abbott,s competitive position in the ... to help laboratories efficiently store, retrieve and ...
Breaking Medicine News(10 mins):Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4
... controls the rapid production and differentiation of the stem cells that ... open the door to more streamlined treatments for leukemia and other ... , ... (Vocus) April 8, 2009 -- Researchers have identified ...
... IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") participated ... at PLA 301 Hospital in Beijing on April 5, ... and Hong Kong attended the inaugural event that focused ... was opened by Dir Chen Xiaohong, Director of PLA ...
... Leadership Conference on April 24 ALEXANDRIA, Va., April 8 ... president and CEO, joined an invitation-only meeting at the ... appointed Director of the White House Office of Health ... to this important meeting is an indicator of the ...
... AJ,s grocery stores sell limited-edition, reusable grocery totes to ... age-old question of "paper or plastic" by choosing to ... Children,s Hospital. Bashas, Food City and AJ,s grocery stores ... Shamrock Farms on a charitable "green" mission this spring. ...
... drug lowers prostate specific antigen (PSA) levels a ... prostate cancer for whom traditional treatment options have failed. ... Center (MSKCC), is published today in Science ... ., Most men with metastatic prostate cancer eventually build ...
... Cancer Researchers and Updates on Key Discoveries, Plus ... April 8 Internationally renowned physician-scientists will discuss ... US, plus important recent discoveries in translational cancer ... Cancer Research Foundation Clinical Investigator Symposium.The ...
Other Medicine News:Health News:Scientists Identify Key Gene That Protects Against Leukemia 2Health News:Scientists Identify Key Gene That Protects Against Leukemia 3Health News:Scientists Identify Key Gene That Protects Against Leukemia 4Health News:Neurosurgeons from around the world gather at PLA 301 Hospital in China 2Health News:NHPCO President/CEO Meets with Nancy-Ann Min DeParle at White House 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 3Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 4Health News:Drug shows activity in men with advanced prostate cancer 2Health News:Drug shows activity in men with advanced prostate cancer 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 2Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 4
(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: ... on significant strategic and financial initiatives at its ... Conference is hosted by Peter H. Soderberg, president ... on the following topics: ,, Status of ... development and financial updates Smart technologies that ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
(Date:12/15/2009)... SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... AMLN ), Eli Lilly and Company (NYSE: ... ALKS ) today announced positive results from ... investigational diabetes therapy, to BYETTA® (exenatide) injection taken ... After 24 weeks of treatment, patients taking exenatide ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 1First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 2First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 3First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 4Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 1Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 2Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
... U.S.-based subsidiary of,Pharmexa A/S, presents selected data ... Influenza Conference entitled, "Options for,the Control of ... The,data show that a "universal" vaccine designed ... mice against,lethal experimental influenza virus challenge. , ...
... SAN FRANCISCO & NEW DELHI, India--(BUSINESS WIRE)--Jun 21, ... non-profit,pharmaceutical company, today announced that Phase 3 research,related ... (Paromomycin), was published in the current issue of ... trial shows,that the medicine paromomycin is safe, effective, ...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4
Enzyme Immunoassay of Protein C Antigenby ELISA Method, 96 tests...
Substrate Plasma for Factor II Assay by STA© Analyzers. Freeze-dried human serum and absorbed bovine plasma, the latter providing factor V and fibrinogen to the test system....
Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: